[特邀报告]Fusion PET/MRI of neuromelanin in substantia nigra using 18F-P3BZA in Patients with Parkinson’s Disease: preliminary results - 报告详情

Fusion PET/MRI of neuromelanin in substantia nigra using 18F-P3BZA in Patients with Parkinson’s Disease: preliminary results
编号:1 访问权限:仅限参会人 更新:2021-11-05 16:47:55 浏览:170次 特邀报告

报告开始:2021年11月14日 13:55 (Asia/Shanghai)

报告时间:25min

所在会议:[PS1] Plenary Session 1 [NM2] Workshop on NM Session 2

暂无文件

摘要
Background: The degeneration of melanized dopaminergic neurons in substantia nigra (SN) is a hallmark of several neurodegenerative diseases such as Parkinson’s disease (PD). A tracer for accurate assessment of neuromelanin (NM) level in SN in vivo is thus required, but until now it still represents as an unmet medical need.
Purpose:We previously demonstrated that N-(2-(diethylamino)-ethyl)-18F-5-fluoropicolinamide (18F-P3BZA) is a promising positron emission tomography (PET) probe for imaging melanin in living subject. In this study, we aim to investigate the feasibility of 18F-P3BZA PET combined with MRI for quantitative detection of neuromelanin (NM) in SN in healthy human volunteers and patients with parkinson’s disease.
Materials and Methods: Specific binding assay of 18F-P3BZA to NM was performed by testing the cell uptake of the probe in neuromelanotic PC12 cells, melanin-rich B16F10 cells, and amelanotic SKOV3 cells at 15, 30, 60, and 120 minutes post-incubation. Ex vivo biodistribution studies were also conducted in melanoma or amelanoma xenografts. 18F-P3BZA PET was performed in 10 healthy human volunteers (median age, 31 years; range, 27–35 years; 3 men) and 30 patients with parkinson’s disease, accompanied with magnetic resonance imaging (MRI) for co-registration. Autoradiography of human brain slides samples was performed accompanied with gross midbrain photos and Fontana-Masson stains for co-registration of SN neuromelanin.
Results:18F-P3BZA accumulation in neuromelanotic PC12 cells and melanotic-rich melanoma cells were significantly higher than that in amelanotic cells. Fusion PET/MRI revealed that 18F-P3BZA accumulated in SN rapidly in healthy human volunteers. Autoradiography showed significant 18F-P3BZA accumulation in healthy SN which contains a high concentration of NM, while no observed 18F-P3BZA uptake outside SN zones in the midbrain. PET/CT scans revealed that the activity of SN in patients with PD decreased compared to healthy controls, as evidenced by a reduction in (18)F-P3BZA uptake (1.36% ID/g ± 0.14 and 3.75% ID/g ± 0.52, respectively; P < .05).
Conclusion The 18F-P3BZA PET is feasible to visualize the nigral neuromelanin in substantia nigra, suggesting it may be used a potential tracer for assessment of pigmented neuronal loss in PD.
关键字
Substantia nigra;neuromelanin;18F-P3BZA;positron emission tomography;Magnetic resonance imaging (MRI);Parkinson’s disease
报告人
Lihong Bu
Professor Renmin Hospital of Wuhan University

Lihong Bu
Professor, Renmin Hospital of Wuhan University

  • Director of PET-CT/MRI Center, Renmin Hospital, Wuhan University
  • Fellow of Oncology Group of Chinese Society of Nuclear Medicine
  • Fellow of Mammology group of Chinese society of Radiology

发表评论
验证码 看不清楚,更换一张
全部评论

倒计时

  • 00

  • 00

  • 00

  • 00

重要日期

摘要提交日期:

2021/08/31

2021/10/25

全文投稿日期:  

2021/09/15

2021/10/25

录取通知日期: 

2021/09/30

2021/11/01

会议日期:   2021-11-12-2021-11-14

联系我们

杨巾英 13675518597
智德波 15056085235
高嵩 13121880288
曹乐 15910809908
会议邮箱: icmipe2021@ustc.edu.cn